If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 126.50
Bid: 125.00
Ask: 128.00
Change: 4.50 (3.69%)
Spread: 3.00 (2.40%)
Open: 122.00
High: 126.50
Low: 122.00
Prev. Close: 122.00
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares & TVR

25 Mar 2024 15:35

RNS Number : 2082I
Transense Technologies PLC
25 March 2024

25 March 2024

Transense Technologies plc

("Transense" or "the Company")

Transaction in own shares

Change to Total Voting Rights

Transense Technologies plc, the provider of specialist sensor technology and measurement systems, announces that on 22 March 2024, the Company purchased 70,000 of its own ordinary shares of 10p each ("Ordinary Shares") at a price of 100 pence per share. These shares will be held in treasury for the time being to satisfy share option awards in the future.

Following these transactions, the total number of Ordinary Shares held as treasury shares by the Company is 1,152,856. The total number of Ordinary Shares in issue (including shares held as treasury shares) is 16,437,740. Therefore, the total number of voting rights in the Company is 15,284,884 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the information below contains information about the purchases made by Shard Capital Stockbrokers on behalf of the Company as part of the buyback programme.

Aggregate information:

Shares purchased:

Transense Technologies plc (ISIN CODE: GB00BDHDTH21)

Date of purchases:

22 March 2024

Investment firm

Shard Capital Stockbrokers

Venue

London Stock Exchange

Number of ordinary shares purchased

70,000

Volume-weighted average price, pence

100

Highest price paid (per ordinary share), pence

100

Lowest price paid (per ordinary share), pence

100

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Stefano Aquilino / Tony Quirke (Sales & Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper/Nick Rome / Joseph Walker

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

Notes to Editors:

Transense is a developer of specialist sensor technology and measurement systems. The Company has two active business divisions:

· Translogik a range of smart, connected tyre inspection and management equipment, used by leading tyre manufacturers, dealers and fleet operators to reduce costs and improve safety; and

· SAWsense, developing Surface Acoustic Wave (SAW) sensor technology, to improve performance, reliability and efficiency in focus markets of aerospace, automotive, robotics and industrial machinery.

In addition, the Company earns residual royalty income from Bridgestone iTrack (new branding name for iTrack), a tyre condition and performance monitoring system, that was developed by Translogik and subsequently licensed to Bridgestone Corporation for a ten year period in 2020, expiring in 2030.

The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from its business divisions by leveraging excellence in innovation and know-how to commercialise technologies through industry partnerships and exposure to global growth markets.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com

For further information please contact transense@walbrookpr.com

Schedule of Purchases - Individual Transactions

Number of Shares

Price Per Share (pence)

Trading Venue

Date of Transaction

Time of transaction

70,000

100

London Stock Exchange

22 March 2024

14:47:58

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSEASDSADLLEFA
Date   Source Headline
1st Aug 20187:00 amRNSTrading Update
25th Jun 20188:29 amRNSHolding(s) in Company
21st Jun 20182:33 pmRNSResult of General Meeting
31st May 20187:00 amRNSPlacing and Notice of General Meeting
8th May 20187:00 amRNSNew Translogik iTrack Contract Win
2nd Mar 201812:26 pmRNSStatement re joint broker
7th Feb 20187:00 amRNSInterim Results
5th Feb 20189:56 amRNSHolding(s) in Company
21st Dec 20171:09 pmRNSResult of AGM
21st Dec 20177:00 amRNSAGM Statement
18th Dec 201711:18 amRNSIssue of Equity
27th Nov 20179:29 amRNSContract Win
14th Nov 20177:00 amRNSNotice of AGM
26th Sep 20177:00 amRNSFinal Results
5th Sep 20177:00 amRNSNotice of Results
5th Sep 20177:00 amRNSInvestor Event
7th Aug 20177:00 amRNSNew iTrack Contract Win with BHP in Australia
31st Jul 20177:00 amRNSTrading Update
27th Jun 20177:00 amRNSAward of options
26th Jun 20177:00 amRNSGlencore - Further Contract Win
6th Jun 20177:00 amRNSDirector/PDMR Shareholding
5th Jun 20177:00 amRNSGlencore - Further Contract Win
4th Apr 20175:20 pmRNSHolding(s) in Company
29th Mar 20177:01 amRNSInterim results
29th Mar 20177:00 amRNSFurther Payment from General Electric
1st Mar 20177:00 amRNSInvestor Event
28th Feb 20171:54 pmRNSNotice of Results
27th Jan 20177:00 amRNSIssue of Equity
22nd Dec 20168:19 amRNSCapital Reduction
23rd Nov 20163:45 pmRNSResult of AGM & Share Consolidation
23rd Nov 20167:00 amRNSAGM Statement
21st Sep 20167:00 amRNSNotice of AGM
21st Sep 20167:00 amRNSFinal Results
25th Aug 20167:00 amRNSInvestor Event
16th Aug 20167:00 amRNSNotice of Results
18th Jul 20167:01 amRNSTrading Update
18th Jul 20167:00 amRNSLicence Agreement with GE
9th Mar 20162:55 pmRNSHolding(s) in Company
2nd Mar 20167:00 amRNSInterim Results
16th Dec 20157:00 amRNSTranslogik Contract Win with Continental
16th Nov 20153:55 pmRNSResult of AGM
16th Nov 20157:00 amRNSAGM Statement
22nd Oct 20157:00 amRNSDirector Dealing
21st Oct 20157:00 amRNSSale of IntelliSAW Division for US$5m
8th Oct 20157:00 amRNSNotice of AGM and Posting of Accounts
28th Sep 20157:00 amRNSPreliminary unaudited results
13th Aug 20157:00 amRNSNew Translogik iTrack Contract Win
29th Jul 201512:36 pmRNSHolding(s) in Company
27th Jul 20151:30 pmRNSResult of General Meeting
27th Jul 20157:00 amRNSGM Statement & Result of Offer for Subscription

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.